AI-Driven Sequence
for
Next-Generation
mRNA Therapeutics.

A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
C
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U
G
C
A
U

Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis •Generate • Validate

Our mRNA medicines are sequence-optimized for

  • Express selectively in the target cell type.
  • Express more protein per mg of drug.
  • Improve drug product shelf life.
  • Enhance in vivo stability for longer-acting drug activity.

our partners

Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis •Generate • Validate

Our Solution

  • Express selectively in the target cell type.
  • Express more protein per mg of drug.
  • Improve drug product shelf life.
  • Enhance in vivo stability for longer-acting drug activity.

Early Access Partners’ Stories

Partners across the genetic medicine:

Early Access

All using nCode-optimizerTM

Amplifying gene editor efficiency

top-tier gene editing company.

Maximizing saRNA

Higher potency and a patient-friendly dosing schedule.

Redefining Delivery

top tier academic center in vivo hematology-oncology CAR-T.

Targeted Delivery

Well-known LNP company evaluating us as a platform partner.

Scientific Team

Thinkhat logo
Thinkhat
Co-founder
Team
Dr.Chris Nelson
Chief Scientific Officer
SivaCh
Dr.Siva Ch
Head of AI
sachin photo
Sachin K
Senior AI Engineer
Shresta V
AI/ML Engineer
Urvesh Trivedi
AI/ML Engineer
Let's optimize together!

What mRNA medicine payload do you want to optimize? In which target cells?

We adapt quickly to your goals;
in as little as one week.